Attention has turned to progressive supranuclear palsy, a rare neurodegenerative disorder. Here's what it is and why it's ...

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...

Approval expands low-dose MRI contrast options for the youngest patients and reflects a positive benefit–risk profile of ...

The gadopiclenol extension for use in infants and neonates offers high-quality MRI contrast enhancement at half the standard gadolinium dose. The FDA has approved an extension of intravenous ...

A University of Houston engineering professor is warning that implanted cuff electrodes—widely used in therapy for epilepsy, depression and inflammatory disorders—could trigger unintended nerve ...

Full-body MRIs are all the rage. We take a look at three major companies offering such testing.

Shoulder pain is the third most common musculoskeletal complaint seen by doctors, affecting approximately 18–31% of the global population each month. Up to 85% of these cases are due to problems with ...

Researchers have found that the severity of autism symptoms, rather than the diagnosis itself, is linked to patterns of brain connectivity associated with genes connected to autism and ADHD.

Late last year, Health Canada approved lecanemab, a monoclonal antibody that clears amyloid plaques — a hallmark indicator of ...